Involvement of per- and polyfluoroalkyl compounds in tumor development
- PMID: 38478087
- PMCID: PMC10965717
- DOI: 10.1007/s00204-024-03685-7
Involvement of per- and polyfluoroalkyl compounds in tumor development
Abstract
Per- and polyfluoroalkyl substances (PFAS) are a large group of synthetic persistent chemicals, which are used in many industrial and commercial applications. Hundreds of different PFAS have been identified in the environment and they are commonly found also in human blood. Due to the chemical stability and extensive use, PFAS pose a risk for human health and wildlife. Mounting evidence indicates that PFAS-exposure adversely affects many organs including liver, kidney, and reproductive tissues and induces tumors in laboratory rodents. Epidemiological studies show association between PFAS-exposure and some tumors also in humans. Effects of PFAS-exposure are complex and obviously do not depend only on the concentration and the structure of PFAS, but also on age and sex of the exposed individuals. It has been difficult to show a causal link between PFAS-exposure and tumors. Moreover, molecular mechanisms of the PFAS effects in different tissues are poorly understood. PFAS are not directly mutagenic and they do not induce formation of DNA binding metabolites, and thus are assumed to act more through non-genotoxic mechanisms. In this review, we discuss the involvement of PFAS-compounds in tumor development in tissues where PFAS exposure has been associated with cancer in epidemiological and animal studies (liver, kidney, testicle and breast). We will focus on molecular pathways and mechanisms related to tumor formation following PFAS-exposure.
Keywords: Breast cancer; Kidney cancer; Liver cancer; Molecular mechanisms; PFAS exposure; Testicular cancer.
© 2024. The Author(s).
Conflict of interest statement
The authors have no competing financial interests to declare that are relevant to the content of this article.
Figures
Similar articles
-
Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research.Environ Toxicol Chem. 2021 Mar;40(3):606-630. doi: 10.1002/etc.4890. Epub 2020 Dec 7. Environ Toxicol Chem. 2021. PMID: 33017053 Free PMC article. Review.
-
Health-related toxicity of emerging per- and polyfluoroalkyl substances: Comparison to legacy PFOS and PFOA.Environ Res. 2022 Sep;212(Pt C):113431. doi: 10.1016/j.envres.2022.113431. Epub 2022 May 13. Environ Res. 2022. PMID: 35569538 Review.
-
Per- and polyfluoroalkyl substances exposure and its influence on the intestinal barrier: An overview on the advances.Sci Total Environ. 2022 Dec 15;852:158362. doi: 10.1016/j.scitotenv.2022.158362. Epub 2022 Aug 30. Sci Total Environ. 2022. PMID: 36055502 Review.
-
Exposure to a mixture of legacy, alternative, and replacement per- and polyfluoroalkyl substances (PFAS) results in sex-dependent modulation of cholesterol metabolism and liver injury.Environ Int. 2021 Dec;157:106843. doi: 10.1016/j.envint.2021.106843. Epub 2021 Aug 31. Environ Int. 2021. PMID: 34479135 Free PMC article.
-
Dietary exposure to per- and polyfluoroalkyl substances: Potential health impacts on human liver.Sci Total Environ. 2024 Jan 10;907:167945. doi: 10.1016/j.scitotenv.2023.167945. Epub 2023 Oct 21. Sci Total Environ. 2024. PMID: 37871818 Review.
Cited by
-
Perfluorooctane Sulfonate (PFOS) and Related Compounds Induce Nuclear Receptor 4A1 (NR4A1)-Dependent Carcinogenesis.Chem Res Toxicol. 2025 Apr 21;38(4):705-716. doi: 10.1021/acs.chemrestox.4c00528. Epub 2025 Mar 11. Chem Res Toxicol. 2025. PMID: 40066943 Free PMC article.
-
Decoding per- and polyfluoroalkyl substances (PFAS) in hepatocellular carcinoma: a multi-omics and computational toxicology approach.J Transl Med. 2025 May 2;23(1):504. doi: 10.1186/s12967-025-06517-z. J Transl Med. 2025. PMID: 40317014 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical